Drug Panel 9, Urine - Screen with Reflex to Confirmation/Quantitation


Abbrev Code:USD9   
Order Code:LAB1244Order Name:Drug Panel 9 Screen Urine w/Reflex to Conf
Order Instructions:Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out drug exposure.
Methodology:Qualitative enzyme multiplied immunoassay technique/Quantitative gas chromatography-Mass spectrometry/liquid chromatography-Tandem mass spectrometry
CPT Codes: 80307 x1, 80307 x1, 80325 x1, 80325 x1, 80345 x1, 80345 x1, 80346 x1, 80346 x1, 80349 x1, 80349 x1, 80353 x1, 80353 x1, 80358 x1, 80358 x1, 80359 x1, 80359 x1, 80361 x1, 80361 x1, 80365 x1, 80365 x1, 80367 x1, 80367 x1, 83992 x1, 83992 x1
Test Includes:See Reference Range.
Turnaround Time:Specimens are sent to reference laboratory Sun-Sat; results are reported within 2-5 days.
Compliance:

This test uses an in vitro diagnostic (IVD) that has been cleared or approved by the FDA.
Associated Links:

Urine Collection Procedure


Collection Instructions

Specimen:Urine, random collection
Optimal Volume:Submit entire collection; analysis requires 8 mL
Minimum\Peds Volume:4 mL
Container:Plastic leakproof container, sterile
Causes for Rejection:Specimens exposed to repeated freeze/thaw cycles.


Processing and Shipping

Specimen Processing:Aliquot 8 mL, 4 mL minimum. Store in refrigerator.
Shipping Instructions:Ship at refrigerated temperature.
Stability:1 week at room temperature; 1 month at refrigerated temperature or frozen.
Test Performed at or Referral Lab Lab Sendouts  (ARUP)
Referral Lab number:0092186


Interpretive

Reference Range:
Drugs/Drug Classes Screen Cutoff
Concentration
THC (Cannabinoids) 20 ng/mL
Cocaine 150 ng/mL
Opiates 300 ng/mL
Oxycodone 100 ng/mL
Phencyclidine 25 ng/mL
Amphetamines 300 ng/mL
MDMA (Ecstasy) 500 ng/mL
Barbiturates 200 ng/mL
Benzodiazepines 200 ng/mL
Methadone 150 ng/mL
Propoxyphene 300 ng/mL
The absence of expected drug(s) and/or drug metabolite(s) may indicate noncomplaince, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. Specimens for which drugs or drug classes are detected by the screen are reflexed to a second, more specific-technology (GS/MS and/or LC-MS/MS). The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

Oxycodone results are reported with the opiates results. MDMA results are reported with the amphetamines results. The following opoids are not detected in this test: fentanyl;. buprenorphine, meperidine, tramadol, and tapentadol. A comprehensive panel that includes these opoids is available or individual opoid testing can be ordered. Refer to aruplab.com for test information.

For medical purposes; not valid for forensic use.


Click HERE to Report test errors or omissions.
*If no email program is associated with this computer, please contact:
[email protected] for TestID: 6952"